VIMPAT
UCB CANADA INC
Quick answers
Is there a shortage of VIMPAT in Canada?
No. There is no current shortage of VIMPAT 150MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
PMS-LACOSAMIDE
PHARMASCIENCE INC
AG-LACOSAMIDE
ANGITA PHARMA INC.
Other Products
SANDOZ LACOSAMIDE
SANDOZ CANADA INCORPORATED
ZDS-LACOSAMIDE
ZYDUS PHARMACEUTICALS (CANADA) INC
TEVA-LACOSAMIDE
TEVA CANADA LIMITED
APO-LACOSAMIDE
APOTEX INC
DIN
02357631
Strength
150MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from UCB CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
160MG · DIN 02525275
320MG · DIN 02553627
320MG · DIN 02553619
160MG · DIN 02525267
10MG · DIN 02452936
75MG · DIN 02452960
100MG · DIN 02452979
10MG · DIN 02452987
50MG · DIN 02452952
10MG · DIN 02452995
25MG · DIN 02452944
200MG · DIN 02465574